PrecisionLife, a leading techbio company driving precision medicine in complex chronic diseases, announced today a data access agreement with the University of Oxford to license the Oxford Endometriosis Gene (OXEGENE) dataset with the aim to develop new personalised treatments for endometriosis patients.
Abivax presents first-half 2024 financial results – Biotech Investments
EQS-News: ABIVAX / Key word(s): Half Year Results Abivax presents first-half 2024 financial results 09.09.2024 / 22:01 CET/CEST The issuer is solely responsible for the